Malignant Anal Neoplasm — Trials

Malignant Anal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 68
Recruiting: 34
Ph III recruiting: 2
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.1%
Trials / 1,000 deaths: 42.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07795801	Mind-Body Sexual Well-Being Program for Female GI Cancer Survivors	not yet recruiting	N/A	100	Massachusetts General HospitalOTHER	1	Sep 8, 2026	clinicaltrials
NCT07790601	Swabs in Screening for HPV (SWISH)(SWISH)	not yet recruiting	N/A	700	Kirby InstituteOTHER_GOV	1	Aug 27, 2026	clinicaltrials